Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0SAN stock hub

LON/0SAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0SANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

27.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0SAN

In the news

Latest news · LON/0SAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.8

P25 12.9P50 16.9P75 23.5

Trailing P/E40.2

P25 15.9P50 22.9P75 35.8

ROE10.4

P25 -54.2P50 2.1P75 13.7

ROIC8.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0SAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	22,356
Employees Change	-2,049%
Employees Change Percent	-9.29
Enterprise value	CHF 30.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CH1243598427
Last refreshed	2026-05-10
Market cap	CHF 27.3B
Price	CHF 66.28
Price currency	CHF
Rev Per Employee	370,802.07x
Sector	Healthcare
Sic	2834
Symbol	lon/0SAN
Website	https://www.sandoz.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.49%
EV Earnings	44.59x
EV/EBIT	28x
EV/EBITDA	20.55x
EV/FCF	37.01x
EV/Sales	3.63x
FCF yield	2.99%
Forward P/E	20.8x
P/B ratio	3.92x
P/E ratio	40.22x
P/S ratio	3.29x
PE Ratio3 Y	85.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.95%
EBITDA Margin	16.96%
FCF margin	9.87%
Gross margin	47.5%
Gross Profit	CHF 3.9B
Gross Profit Growth	6.92%
Gross Profit Growth Q	13.12%
Gross Profit Growth3 Y	5.06%
Gross Profit Growth5 Y	3.19%
Net Income	CHF 679.1M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth5 Y	8.32%
Pretax Margin	10.82%
Profit Margin	8.19%
Profit Per Employee	CHF 30,377
Profitable Years	6
ROA	4.31
Roa5y	3.17
ROCE	9.55
ROE	10.42
Roe5y	6.57
ROIC	8.2
Roic5y	5.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	81.83%
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth5 Y	7.95
FCF Growth	336.91%
FCF Growth Q	315.43%
FCF Growth3 Y	102.8%
FCF Growth5 Y	10.84%
OCF Growth	142.99%
OCF Growth Q	150.82%
OCF Growth3 Y	46.59%
OCF Growth5 Y	10.54%
Revenue Growth	7.44x
Revenue Growth Q	10.71x
Revenue Growth Quarters	1x
Revenue Growth Years	4x
Revenue Growth3 Y	3.34x
Revenue Growth5 Y	3.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.53
Assets	CHF 16.4B
Cash	CHF 1.3B
Current Assets	CHF 6B
Current Liabilities	CHF 5.1B
Debt	CHF 4.2B
Debt EBITDA	CHF 2.89
Debt Equity	CHF 0.61
Debt FCF	CHF 5.18
Equity	CHF 7B
Interest Coverage	6.57
Liabilities	CHF 9.4B
Long Term Assets	CHF 10.4B
Long Term Liabilities	CHF 4.3B
Net Cash	CHF -2.9B
Net Cash By Market Cap	CHF -10.77
Net Debt EBITDA	CHF 2.09
Net Debt Equity	CHF 0.42
Net Debt FCF	CHF 3.6
Tangible Book Value	CHF -369.3M
Tangible Book Value Per Share	CHF -0.85
WACC	6.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.18
Inventory Turnover	2.08
Net Working Capital	CHF 159.7M
Quick ratio	0.72
Working Capital	CHF 943.6M
Working Capital Turnover	CHF 6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%
Dividend Growth	36.64%
Dividend Growth Years	2%
Dividend per share	CHF 0.75
Dividend Years	3
Dividend Yield	1.19%
Ex Div Date	2026-04-13
Last Dividend	CHF 0.75
Payout Frequency	Annual
Payout Ratio	34.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	81.75%
200-day SMA	56.4
50-day SMA	64.05
50-day SMA vs 200-day SMA	50over200
All Time High	72.69
All Time High Change	-8.82%
All Time High Date	2026-02-25
All Time Low	23.5
All Time Low Change	182.05%
All Time Low Date	2023-11-09
ATR	1.92
Beta	0.53
Ch YTD	14.62
High	67.54
High52	72.69
High52 Date	2026-02-25
High52ch	-8.82%
Low	66.12
Low52	36.2
Low52 Date	2025-05-08
Low52ch	83.1%
Ma50ch	3.48%
Price vs 200-day SMA	17.52%
RSI	58.82
RSI Monthly	71.34
RSI Weekly	62.95
Sharpe ratio	2.09x
Sortino ratio	3.78
Total Return	0.55%
Tr YTD	16.01
Tr1m	5.64%
Tr1w	4.96%
Tr3m	9.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 1.1B
Operating Income Growth	150.4
Operating Income Growth3 Y	80.68
Operating Income Growth5 Y	7.62
Operating margin	12.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	414,325,351%
Net Borrowing	89,488,708
Shares Insiders	0.02%
Shares Institutions	39.22%
Shares Qo Q	0.46%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 742.3M
Average Volume	179,784.9x
Bv Per Share	16.11
CAPEX	CHF -366.3M
Ch1m	4.37
Ch1w	4.96
Ch1y	79.57
Ch3m	7.91
Ch6m	25.34
Change	-0.66%
Change From Open	-0.03
Close	66.72
Days Gap	-0.63
Depreciation Amortization	327,880,758
Dollar Volume	3,184,189.2
Earnings Date	2026-08-05
EBIT	CHF 1.1B
EBITDA	CHF 1.4B
EPS	CHF 1.55
F Score	7
FCF	CHF 818M
FCF EV Yield	2.7x
Financing CF	-146,371,000
Fiscal Year End	December
Founded	1,886
Goodwill	5,878,381,196
Graham Number	25.04802
Graham Upside	-62.21
Income Tax	CHF 217.7M
Investing CF	-728,140,000
Is Primary Listing	0
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Lynch Fair Value	CHF 13.71
Lynch Upside	-79.32
Ma150	59.2
Ma150ch	11.96%
Ma20	64.89
Ma20ch	2.15%
Net CF	407,164,000
Next Earnings Date	2026-08-05
Open	66.3
P FCF Ratio	33.39
P OCF Ratio	23.06
Payment Date	2026-04-15
Position In Range	11.31
Ppne	2,039,168,920
Price Date	2026-05-08
Price EBITDA	CHF 19.43
Relative Volume	0.27x
Revenue	8,289,651,000x
SBC By Revenue	0.91x
Share Based Comp	75,786,000
Tax By Revenue	2.63x
Tax Rate	24.28%
Tr6m	26.87%
Volume	48,041
Z Score	2.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0SAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.75 annual per share

Payout ratio

+34.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-04-13

Performance

LON/0SAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0SAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.2%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

LON/0SAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.8

Neutral momentum band

Price vs 200-day MA

+17.5%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

2.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0SAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0SAN stock rating?

lon/0SAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0SAN analysis?

The full report lives at /stocks/lon/0SAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0SAN?

The latest report frames lon/0SAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0SAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.